论文部分内容阅读
目的:探讨子宫内膜异位症不孕应用红藤方联合促排卵治疗的疗效观察。方法:选择自2011年12月—2013年12月在我院诊治的子宫内膜异位症不孕患者68例,随机分为两组,每组34例,单用枸橼酸克罗米芬作为对照组,红藤方联合枸橼酸克罗米芬作为研究组,分析两组临床疗效、治疗后相关指标情况。结果:研究组总有效率91.18%,对照组总有效率70.58%,两组比较差异有统计学意义(P<0.05);研究组患者卵泡数和排卵日的子宫内膜相关厚度指标,比对照组患者高,两组比较差异具有统计学意义(P<0.05);研究组患者子宫内膜相关A类型和妊娠率,比对照组患者高,且研究组LUFS发生率比对照组低,差异有统计学意义(P<0.05)。结论:对子宫内膜异位症的不孕予红藤方联合枸橼酸克罗米芬促排卵,疗效显著,且相关指标改善明显,具有一定临床应用和研究价值。
Objective: To investigate the curative effect of endometriosis infertility combined with oxytocin in the treatment of infertility. Methods: Sixty-eight patients with endometriosis infertility who were diagnosed and treated in our hospital from December 2011 to December 2013 were randomly divided into two groups (34 in each group), with clomiphene citrate alone as control Group, triptolide combined clomiphene citrate as a research group, analysis of the clinical efficacy of the two groups, after treatment, related indicators. Results: The total effective rate was 91.18% in the study group and 70.58% in the control group, the difference between the two groups was statistically significant (P <0.05). The thickness of the endometrium related to the number of follicles and ovulation day in the study group were significantly higher than those in the control (P <0.05). The type A and pregnancy rate of endometrium in study group were higher than those in control group, and the incidence of LUFS in study group was lower than that in control group Statistical significance (P <0.05). Conclusion: The infertility with endometriosis is associated with ovulation induction by Clofibrate and triptolide combined with clomiphene citrate. The curative effect is obvious, and the related indexes are improved obviously. It has some clinical application and research value.